These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 26284476)

  • 1. A bird's eye view of NK cell receptor interactions with their MHC class I ligands.
    Saunders PM; Vivian JP; O'Connor GM; Sullivan LC; Pymm P; Rossjohn J; Brooks AG
    Immunol Rev; 2015 Sep; 267(1):148-66. PubMed ID: 26284476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of natural killer cell surface receptors.
    Radaev S; Sun PD
    Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
    Pietra G; Romagnani C; Moretta L; Mingari MC
    Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
    Sullivan LC; Clements CS; Rossjohn J; Brooks AG
    Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC.
    Wroblewski EE; Parham P; Guethlein LA
    Front Immunol; 2019; 10():177. PubMed ID: 30837985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells: tuned by peptide?
    Das J; Khakoo SI
    Immunol Rev; 2015 Sep; 267(1):214-27. PubMed ID: 26284480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
    MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
    FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
    O'Callaghan CA
    Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
    Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
    Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
    J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.